Maven Bio
PrivateLast Round
Seed
Apr 17, 2025
Total Funding Raised
$5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Maven Bio operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Seed round in April 2025.
Maven Bio is a healthcare technology company that develops a live intelligence platform for biopharma teams to monitor clinical, regulatory, and market developments.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Business Intelligence, Medical AI, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Maven Bio Comparables
Compare Maven Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| One Zyme | 89% | |
| S&P Global Inc. | 76% | |
| BioCentury Inc. | 72% |
For institutional investors. Book with your work email.
Maven Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Maven Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NVO Capital | Seed |
| Pags Group | Seed |
| Y Combinator | Seed |
| Splash Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 66% MoM, reaching 12.1K.
- Jul 26, 2026
Three of the top 10 pharmaceutical companies are now customers.
For institutional investors. Book with your work email.
Maven Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Maven Bio's valuation, stock price, and market status.
Is Maven Bio a public or private company?
Maven Bio is a private company.
What is the current stock price of Maven Bio?
Maven Bio is a private company, so its shares have no public market price. Caplight tracks Maven Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Maven Bio worth (valuation)?
Valuation information for Maven Bio is not publicly available.
Can I buy Maven Bio stock?
Maven Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Maven Bio's last funding round?
Maven Bio's most recent funding round was Seed on April 17, 2025.
Who are the main investors in Maven Bio?
Key investors in Maven Bio include NVO Capital, Pags Group, Y Combinator, Splash Capital.
Will Maven Bio IPO soon?
No public IPO plans have been announced for Maven Bio.
How can I track Maven Bio secondary market activity?
Caplight tracks bids, offers, and trades in Maven Bio's shares on secondary markets.